Login:
 
Thompson J. Engagement with HCV therapy linked to lower deaths from all causes in injecting drug users. Practitioner October 2020;264(1841):9

Engagement with HCV therapy linked to lower deaths from all causes in injecting drug users

27 Oct 2020Registered users

Engagement with hepatitis C treatment by people who inject drugs is associated with a lower risk of all-cause mortality and drug-related death, a study set in Scotland has found.

Registered usersThis article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.

To buy this article (£25+tax) copy the article citation above and click Buy article